These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22420544)
21. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties. Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093 [TBL] [Abstract][Full Text] [Related]
22. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure. Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647 [TBL] [Abstract][Full Text] [Related]
23. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights. Abyar F; Tabrizi L Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands. Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197 [TBL] [Abstract][Full Text] [Related]
25. A new gold(I) complex-Au(PPh Li X; Huang Q; Long H; Zhang P; Su H; Liu J EBioMedicine; 2019 Jan; 39():159-172. PubMed ID: 30527624 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates. Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149 [TBL] [Abstract][Full Text] [Related]
27. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid. Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, DFT study, DNA/BSA-binding affinity, and cytotoxicity of some dinuclear and trinuclear gold(III) complexes. Radisavljević S; Ćoćić D; Jovanović S; Šmit B; Petković M; Milivojević N; Planojević N; Marković S; Petrović B J Biol Inorg Chem; 2019 Oct; 24(7):1057-1076. PubMed ID: 31489480 [TBL] [Abstract][Full Text] [Related]
29. Chemical biology of anticancer gold(III) and gold(I) complexes. Zou T; Lum CT; Lok CN; Zhang JJ; Che CM Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756 [TBL] [Abstract][Full Text] [Related]
30. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. Messori L; Abbate F; Marcon G; Orioli P; Fontani M; Mini E; Mazzei T; Carotti S; O'Connell T; Zanello P J Med Chem; 2000 Sep; 43(19):3541-8. PubMed ID: 11000008 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer. Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688 [TBL] [Abstract][Full Text] [Related]
32. Highly cytotoxic gold(i)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cells. Le HV; Babak MV; Ehsan MA; Altaf M; Reichert L; Gushchin AL; Ang WH; Isab AA Dalton Trans; 2020 Jun; 49(22):7355-7363. PubMed ID: 32432621 [TBL] [Abstract][Full Text] [Related]
33. A Gold(III) Pincer Ligand Scaffold for the Synthesis of Binuclear and Bioconjugated Complexes: Synthesis and Anticancer Potential. Bertrand B; O'Connell MA; Waller ZAE; Bochmann M Chemistry; 2018 Mar; 24(14):3613-3622. PubMed ID: 29334159 [TBL] [Abstract][Full Text] [Related]
34. Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells. Hyun Kim J; Ofori S; Mertens RT; Parkin S; Awuah SG ChemMedChem; 2021 Oct; 16(20):3222-3230. PubMed ID: 34159760 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides. Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193 [TBL] [Abstract][Full Text] [Related]